Infectious Diseases

/Infectious Diseases
­
18 09, 2015

FDA Regulation of Lab Developed Tests – Keeping Track of the Dialogue

By |September 18th, 2015|Infectious Diseases, Lab Developed Tests|Comments Off on FDA Regulation of Lab Developed Tests – Keeping Track of the Dialogue

The U.S. Food and Drug Administration (FDA) defines a Laboratory Developed Test (LDT) as “a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory”. While some LDTs are relatively simple tests that measure single analytes, others are complex and measure or detect numerous analytes. Examples of LDTs include [...]

28 07, 2015

July 28 is World Hepatitis Day

By |July 28th, 2015|Infectious Diseases, World Hepatitis Day|Comments Off on July 28 is World Hepatitis Day

According to the reports from the World Health Organization (WHO), 400 million people are living with hepatitis B and C worldwide, while 1.4 million die due to these infections every year. In 2010, WHO decided to observe July 28 every year as World Hepatitis Day. This particular date was chosen in honor of the birthday [...]

6 07, 2015

Infection Control Market – Global Forecast to 2020

By |July 6th, 2015|Disinfectants, Infectious Diseases|Comments Off on Infection Control Market – Global Forecast to 2020

According to a research report from Markets and Markets, the global infection control market will reach $16.7 billion by 2020, growing at a CAGR of 6.7% during the forecast period (2015 to 2020). The report list the key factors driving the market as the rising aging population, prevalence of chronic diseases, increase in the number [...]

6 05, 2015

Multiplex PCR Tests to Diagnose Infectious Diseases

By |May 6th, 2015|Infectious Diseases, Multiplex PCR Tests|Comments Off on Multiplex PCR Tests to Diagnose Infectious Diseases

Recent advancements in molecular biology techniques promote the rapid identification of infections with greater accuracy than conventional methods. Successfully applied in many areas of DNA testing including molecular diagnosis of infectious disease, multiplex PCR (Polymerase Chain Reaction) is a widespread molecular biology technique for amplification of multiple targets in a single PCR experiment. This assay [...]

13 04, 2015

Study Values Global Blood Screening Market at $2.5 Billion By 2019

By |April 13th, 2015|Infectious Diseases, Laboratory Tests|Comments Off on Study Values Global Blood Screening Market at $2.5 Billion By 2019

Blood screening determines a person’s eligibility to donate blood. From first-generation ELISA to advanced NAT (nucleic acid tests) technologies, this market has witnessed technological advancements. According to a recently published Markets and Markets research report, the blood screening market is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, with at a [...]

12 01, 2015

Infectious Disease Diagnostics Market to Reach $18,156.2 Million by 2019

By |January 12th, 2015|Infectious Diseases, Lab Equipment|Comments Off on Infectious Disease Diagnostics Market to Reach $18,156.2 Million by 2019

Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, and parasites. Rapid diagnostic tests are now available that improve management and control of infectious disease. Many different types of laboratory tests are available that use blood, urine or other tissue from the body to identify microorganisms. According to a recent report from Markets [...]

29 12, 2014

Handling Specimens from PUI for EVD – Need for Laboratory Specific Plan

By |December 29th, 2014|Ebola, Infectious Diseases|Comments Off on Handling Specimens from PUI for EVD – Need for Laboratory Specific Plan

Recent reports indicate that the Ebola outbreak may last until the end of 2015 as the vaccines need more time to be tested. While specialized centers have been built to provide people with proper medical treatment, continual efforts are needed to fight Ebola which, according to the World Health Organization (WHO), has claimed about 7,300 [...]

22 12, 2014

Molecular Assays for Better Management of RTIs and Influenza

By |December 22nd, 2014|Infectious Diseases|Comments Off on Molecular Assays for Better Management of RTIs and Influenza

The holiday season is here and people need to remember that it is also the flu season. The Centers for Disease Prevention and Control estimates that, every year, influenza affects 5 percent to 10 percent of adults and 20 percent to 30 percent of children globally and causes about 3,000 and 49,000 deaths in the [...]

2 12, 2014

Ebola – ‘Promising’ Vaccine Offers New Hope

By |December 2nd, 2014|Ebola, Infectious Diseases|Comments Off on Ebola – ‘Promising’ Vaccine Offers New Hope

A new intramuscular vaccine has been developed at the US National Institute of Allergy and Infectious Diseases (NIAID) and Okairos, a biotechnology company acquired by GlaxoSmithKline. Following the first human trial of this experimental vaccine against Ebola virus disease (EVD), scientists at NIAID have described it as 'promising'. Their research was published in the New [...]

14 11, 2014

Studies Reveal Why Some People Survive Ebola

By |November 14th, 2014|Ebola, Infectious Diseases|Comments Off on Studies Reveal Why Some People Survive Ebola

Several experts have been looking into the question as to why some people survive Ebola and others don't. A study published last month based on the analysis of the first Ebola cases in Sierra Leone seems to provide some answers. The factors identified by this study are as follows: Pace at which the virus replicates [...]